These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 18286501

  • 21. Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience.
    Van Winkle P, Angiolillo A, Krailo M, Cheung YK, Anderson B, Davenport V, Reaman G, Cairo MS.
    Pediatr Blood Cancer; 2005 Apr; 44(4):338-47. PubMed ID: 15503297
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe.
    Fermand JP, Katsahian S, Divine M, Leblond V, Dreyfus F, Macro M, Arnulf B, Royer B, Mariette X, Pertuiset E, Belanger C, Janvier M, Chevret S, Brouet JC, Ravaud P, Group Myelome-Autogreffe.
    J Clin Oncol; 2005 Dec 20; 23(36):9227-33. PubMed ID: 16275936
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.
    Socinski MA, Smit EF, Lorigan P, Konduri K, Reck M, Szczesna A, Blakely J, Serwatowski P, Karaseva NA, Ciuleanu T, Jassem J, Dediu M, Hong S, Visseren-Grul C, Hanauske AR, Obasaju CK, Guba SC, Thatcher N.
    J Clin Oncol; 2009 Oct 01; 27(28):4787-92. PubMed ID: 19720897
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. High dose chemotherapy with ABMT in soft tissue sarcomas: a report of 22 cases.
    Dumontet C, Biron P, Bouffet E, Blay JY, Meckenstock R, Chauvin F, Philip I, Clavel M, Brunat-Mentigny M, Philip T.
    Bone Marrow Transplant; 1992 Nov 01; 10(5):405-8. PubMed ID: 1464000
    [Abstract] [Full Text] [Related]

  • 28. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
    Massimino M, Gandola L, Spreafico F, Luksch R, Collini P, Giangaspero F, Simonetti F, Casanova M, Cefalo G, Pignoli E, Ferrari A, Terenziani M, Podda M, Meazza C, Polastri D, Poggi G, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1031-7. PubMed ID: 16343801
    [Abstract] [Full Text] [Related]

  • 29. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
    Paulino AC, Nguyen TX, Mai WY, Teh BS, Wen BC.
    Pediatr Blood Cancer; 2007 Aug 15; 49(2):145-8. PubMed ID: 16732580
    [Abstract] [Full Text] [Related]

  • 30. High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
    Milano GM, Cozza R, Ilari I, De Sio L, Boldrini R, Jenkner A, De Ioris M, Inserra A, Dominici C, Donfrancesco A.
    Cancer; 2006 Apr 15; 106(8):1838-45. PubMed ID: 16532434
    [Abstract] [Full Text] [Related]

  • 31. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue.
    Grodman H, Wolfe L, Kretschmar C.
    Pediatr Blood Cancer; 2009 Jul 15; 53(1):33-6. PubMed ID: 19326417
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.
    Maurel J, López-Pousa A, de Las Peñas R, Fra J, Martín J, Cruz J, Casado A, Poveda A, Martínez-Trufero J, Balañá C, Gómez MA, Cubedo R, Gallego O, Rubio-Viqueira B, Rubió J, Andrés R, Sevilla I, de la Cruz JJ, Del Muro XG, Buesa JM.
    J Clin Oncol; 2009 Apr 10; 27(11):1893-8. PubMed ID: 19273704
    [Abstract] [Full Text] [Related]

  • 33. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
    Kushner BH, Cheung IY, Kramer K, Modak S, Cheung NK.
    Pediatr Blood Cancer; 2007 Apr 10; 48(4):430-4. PubMed ID: 16421906
    [Abstract] [Full Text] [Related]

  • 34. [Results of the treatment of non-rhabdomyosarcomatous soft tissue neoplasms within the scope of the CWS 81 study].
    Treuner J, Suder J, Gerein V, Beck J, Winkler K, Weinel F, Gnekow A, Niethammer D.
    Klin Padiatr; 1987 Apr 10; 199(3):209-17. PubMed ID: 3626423
    [Abstract] [Full Text] [Related]

  • 35. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
    Breitfeld PP, Lyden E, Raney RB, Teot LA, Wharam M, Lobe T, Crist WM, Maurer HM, Donaldson SS, Ruymann FB.
    J Pediatr Hematol Oncol; 2001 May 10; 23(4):225-33. PubMed ID: 11846301
    [Abstract] [Full Text] [Related]

  • 36. Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.
    Kondagunta GV, Bacik J, Sheinfeld J, Bajorin D, Bains M, Reich L, Deluca J, Budnick A, Ishill N, Mazumdar M, Bosl GJ, Motzer RJ.
    J Clin Oncol; 2007 Jan 01; 25(1):85-90. PubMed ID: 17194908
    [Abstract] [Full Text] [Related]

  • 37. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ, Xu F, Wang SS, Luo HY, Wang F, Li FH, Sun XF, Xu GC, Lin TY, Huang HQ, Jiang WQ, Guan ZZ, Xu RH.
    Ai Zheng; 2007 Dec 01; 26(12):1344-9. PubMed ID: 18076798
    [Abstract] [Full Text] [Related]

  • 38. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T, Children's Cancer Group.
    J Clin Oncol; 2005 Oct 20; 23(30):7621-31. PubMed ID: 16234523
    [Abstract] [Full Text] [Related]

  • 39. High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma.
    Carli M, Colombatti R, Oberlin O, Stevens M, Masiero L, Frascella E, Koscielniak E, Treuner J, Pinkerton CR.
    J Clin Oncol; 1999 Sep 20; 17(9):2796-803. PubMed ID: 10561355
    [Abstract] [Full Text] [Related]

  • 40. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
    Stevens MC, Rey A, Bouvet N, Ellershaw C, Flamant F, Habrand JL, Marsden HB, Martelli H, Sanchez de Toledo J, Spicer RD, Spooner D, Terrier-Lacombe MJ, van Unnik A, Oberlin O.
    J Clin Oncol; 2005 Apr 20; 23(12):2618-28. PubMed ID: 15728225
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.